Karim Fizazi Selected Research

Everolimus

12/2017	Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy.
4/2014	Tumor growth rate provides useful information to evaluate sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: an integrated analysis of the TARGET and RECORD phase 3 trial data.
12/2010	Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with everolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karim Fizazi Research Topics

Disease

267	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 03/2002
85	Neoplasms (Cancer) 10/2023 - 02/2002
68	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2002
40	Pain (Aches) 07/2023 - 03/2003
26	Disease Progression 11/2023 - 06/2014
22	Fatigue 02/2024 - 01/2012
15	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2023 - 10/2004
14	Seminoma 03/2023 - 08/2003
12	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 07/2003
11	Hypertension (High Blood Pressure) 12/2023 - 05/2011
8	Neutropenia 12/2023 - 02/2013
7	Asthenia 12/2023 - 04/2015
7	Circulating Neoplastic Cells 01/2020 - 01/2016
6	Breast Neoplasms (Breast Cancer) 07/2023 - 04/2009
6	Nausea 01/2023 - 05/2013
6	Febrile Neutropenia 01/2022 - 02/2013
6	Bone Resorption 01/2013 - 07/2003
5	Testicular Neoplasms (Testicular Cancer) 12/2023 - 08/2011
5	Edema (Dropsy) 03/2022 - 11/2012
4	Adenocarcinoma 01/2024 - 12/2007
4	Anemia 12/2023 - 02/2014
4	Residual Neoplasm 12/2023 - 03/2008
4	Pneumonia (Pneumonitis) 01/2022 - 04/2015
4	Diarrhea 10/2021 - 09/2012
4	Kidney Neoplasms (Kidney Cancer) 01/2020 - 04/2014
4	Carcinoma (Carcinomatosis) 07/2009 - 10/2002
3	Heart Failure 12/2023 - 11/2012
3	Teratoma (Teratoid Tumor) 01/2023 - 05/2007
3	Cancer Pain 01/2022 - 01/2013
3	Hypocalcemia 02/2019 - 02/2014
3	Osteonecrosis (Kienbock's Disease) 02/2019 - 01/2012
3	Seizures (Absence Seizure) 01/2019 - 09/2012
3	Hypokalemia 01/2018 - 05/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2016 - 07/2006

Drug/Important Bio-Agent (IBA)

71	Docetaxel (Taxotere)FDA Link 04/2024 - 09/2004
68	AndrogensIBA 05/2024 - 03/2002
48	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 07/2003
47	enzalutamideIBA 01/2024 - 09/2012
40	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 03/2002
38	Hormones (Hormone)IBA 05/2024 - 10/2008
36	Prednisone (Sone)FDA LinkGeneric 02/2022 - 05/2011
35	Abiraterone AcetateIBA 11/2023 - 05/2011
29	abirateroneIBA 11/2023 - 05/2011
25	darolutamideIBA 04/2024 - 08/2014
17	cabazitaxel FDA Link 04/2024 - 06/2014
17	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2002
16	Denosumab FDA Link 02/2019 - 04/2009
14	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023 - 01/2020
13	taxaneIBA 01/2024 - 01/2010
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2010
11	AntigensIBA 04/2024 - 05/2015
10	Diphosphonates (Bisphosphonates)IBA 02/2016 - 04/2009
9	talazoparibIBA 01/2024 - 01/2021
9	Estramustine FDA Link 10/2023 - 09/2004
8	Zoledronic Acid (Zometa)FDA Link 02/2019 - 03/2011
7	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 01/2020
7	Testosterone (Sustanon)FDA Link 09/2023 - 08/2014
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
7	IpilimumabIBA 01/2021 - 06/2014
7	collagen type I trimeric cross-linked peptideIBA 09/2015 - 04/2009
7	Monoclonal AntibodiesIBA 07/2015 - 04/2009
6	Taxoids (Taxanes)IBA 02/2024 - 06/2013
6	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2018
6	olaparibIBA 11/2023 - 01/2020
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 12/2002
6	rucaparibIBA 01/2023 - 01/2020
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2006
6	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 10/2002
6	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2017
6	Alkaline PhosphataseIBA 01/2020 - 01/2013
5	Radium-223IBA 01/2022 - 11/2015
5	TabletsIBA 01/2022 - 01/2016
5	RadiopharmaceuticalsIBA 01/2020 - 05/2009
5	Androgen Receptor AntagonistsIBA 10/2019 - 12/2017
4	PlacebosIBA 02/2022 - 01/2018
4	NivolumabIBA 01/2022 - 10/2016
4	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020 - 01/2013
4	Hemoglobins (Hemoglobin)IBA 01/2020 - 07/2015
4	Gemcitabine FDA Link 01/2019 - 09/2003
4	CreatinineIBA 09/2015 - 04/2009
4	Endothelins (Endothelin)IBA 05/2013 - 07/2003
3	Poly Adenosine Diphosphate RiboseIBA 07/2023 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2016
3	antiarrhythmic peptide (AAP)IBA 02/2022 - 11/2018
3	Opiate AlkaloidsIBA 01/2022 - 01/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2019
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 02/2013
3	cabozantinibIBA 01/2020 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 01/2013
3	Everolimus FDA Link 12/2017 - 12/2010
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2016 - 10/2004

Therapy/Procedure

210	Castration 04/2024 - 03/2002
135	Therapeutics 05/2024 - 03/2003
97	Drug Therapy (Chemotherapy) 04/2024 - 02/2002
22	Radiotherapy 04/2024 - 08/2003
10	Aftercare (After-Treatment) 09/2023 - 05/2009
6	Immunotherapy 01/2020 - 12/2006
5	Precision Medicine 09/2023 - 01/2014
5	Duration of Therapy 10/2022 - 10/2011
4	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 01/2012